Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Q4 Results LIVE Updates: Max Health shares decline 7%, Honasa Consumer up 7%; Hindalco report today
Q4 Results Live Update: Another busy earnings week ends with three Nifty names - Sun Pharma, Eicher Motors and Hindalco reporting their results today, along with broader market names like Torrent Pharma, Fortis Healthcare, DAM Capital, Colgate-Palmolive, IRCON International, Jubilant Pharmova, Minda Corp, and many others. LG, LIC, GAIL, ITC, will also be reacting to their results reported on Thursday.
Bosch among 5 F&O stocks with a sharp rise in futures open interest
Five stocks from the NSE F&O segment witnessed a sharp rise in futures open interest on May 21, indicating increased trading activity and fresh position build-up. The rise in open interest reflects stronger participation from traders, signalling growing conviction and potential momentum in derivatives-driven market action across select counters.
Aditya Birla Group bets big on IPL boom, says media rights frenzy is far from over
Aditya Birla Group sees strong future growth for Indian sports. The group believes IPL media rights will keep increasing in value. This is despite current worries about fewer bidders. India's economy and sports viewership are rising. Premium sports assets are also scarce. This supports future valuations. The group recently bought Royal Challengers Bengaluru. They are optimistic about the long-term trend.
Stocks in news: ITC, LIC, Sun Pharma, Maruti Suzuki, Fino Payments Bank
Benchmark indices experienced a negative close on Thursday, marked by volatile trade and profit booking. Analysts anticipate the Nifty to continue its consolidation between 23,200 and 23,900. Several companies, including ITC, LIC, Sun Pharma, Maruti Suzuki, and Fino Payments Bank, are in focus due to Q4 results and other developments.
Buy, Sell Or Hold: Hitachi Energy, JK Tyre, Aditya Birla Capital, PNB, Maruti Suzuki, GAIL — Ask Profit
Buy Sell Hold
Stocks to Watch for May 21: Aditya Birla Capital, Dr Reddy's Lab, Jubilant Food, Bosch India and more
From Dr Reddy's Laboratories announcing the launch of its oral semaglutide biosimilar in India under the brand name Obeda to Whirlpool of India Ltd reporting a 32.7% year-on-year decline in net profit Q4, here are some stocks to track ahead of Thursday trading session.
TVS Motor Shares Jump As Morgan Stanley Eyes 30-Day Uptrend — Check Target Price
Shares of TVS Motor Company opened at Rs 3,285.40 on the NSE, over 1% higher than its previous close of Rs 3,283.40. The stock gained momentum and rose nearly 3% to hit an intraday high of Rs 3,368 apiece on the NSE.
Liberty Mutual Insurance raises stake in Indian venture
Liberty Mutual Insurance has boosted its stake in Liberty General Insurance to 74 percent. This move strengthens its position in India's non-life insurance sector. Liberty General Insurance began operations in 2013. The insurer reported a 25 percent increase in gross written premium in FY26. Its market share was 0.84 percent at the end of March 2026.
Selling at higher levels turns 23,800 into key barrier for Nifty: Analysts
Benchmark Nifty closed lower last week. Analysts anticipate continued range-bound trading for Nifty this week. Trading strategies suggest buying on dips and selling on rallies within the 23,800-23,200 range. Specific stock recommendations include Indus Towers, Samvardhana Motherson International, Aditya Birla Capital, Sun Pharmaceutical Industries, and Arvind Limited. Investors are advised to consider these opportunities.
Hero MotoCorp lines up Rs 1,500 crore capex for FY27 to double scooter production capacity
Hero MotoCorp plans a significant Rs 1,500 crore capital expenditure for fiscal year 2027. This investment aims to double its scooter production capacity. The company is also building a global parts centre in South India with an investment exceeding Rs 700 crore. Demand momentum remains strong despite global uncertainties.
Why JLR remains elephant in the room for Tata Motors despite domestic momentum
Tata Motors’ India passenger vehicle business delivered robust FY26 growth led by SUVs and EVs, but mounting pressures at Jaguar Land Rover continue to overshadow the recovery story.
ET Graphics: Auto industry opens FY27 in top gear despite geopolitical tensions
India’s automobile industry began FY27 on a strong footing, with robust vehicle sales across segments despite ongoing geopolitical uncertainties and global economic concerns. Strong consumer demand, improved rural sentiment and continued momentum in passenger and two-wheeler categories helped automakers post healthy growth at the start of the new financial year.